Literature DB >> 31186793

miR-144 suppresses cell proliferation and invasion in gastric cancer through downregulation of activating enhancer-binding protein 4.

Faheim Mushtaq1, Jinping Zhang1, Jiansheng Li1.   

Abstract

Gastric cancer (GC) is the most common malignant disease and its incidence rate is increasing rapidly worldwide. The molecular mechanisms underlying GC tumorigenesis require further investigation. The expression and physiological roles of microRNA-144 (miR-144) have been investigated in numerous types of tumor. However, its biological function in GC remains largely unknown. The reverse transcription- quantitative polymerase chain reaction was used to determine the expression of miR-144 in GC cells and normal gastric epithelial cells. An miR-144 mimic was transfected into HGC-27 cells. In addition, bioinformatics analysis was performed to identify the potential targets of miR-144. Protein expression, luciferase and rescue assays were used to confirm the target of miR-144. It was identified that the expression of miR-144 was significantly downregulated in GC cells compared with in normal gastric epithelial cells. Furthermore, overexpression of miR-144 suppressed HGC-27 cell proliferation, migration and invasion. Additionally, bioinformatics analysis suggested that the activating enhancer-binding protein 4 (AP4) is a target gene of miR-144. In addition, it was determined that miR-144 suppresses the expression of AP4 by binding directly to its 3'-untranslated regions. Furthermore, restoration of AP4 partially attenuated miR-144-induced inhibition of cell proliferation, migration and invasion. Therefore, the results of the present study suggest that miR-144 serves an important role in GC progression.

Entities:  

Keywords:  activating enhancer-binding protein 4; gastric cancer; invasion; microRNA-144; proliferation

Year:  2019        PMID: 31186793      PMCID: PMC6507332          DOI: 10.3892/ol.2019.10214

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

Review 1.  microRNAs: tiny regulators with great potential.

Authors:  V Ambros
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 4.  MicroRNAs: key participants in gene regulatory networks.

Authors:  Xi-Song Ke; Chang-Mei Liu; De-Pei Liu; Chih-Chuan Liang
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

5.  AP4 encodes a c-MYC-inducible repressor of p21.

Authors:  Peter Jung; Antje Menssen; Doris Mayr; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

6.  A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells.

Authors:  Mi-Young Kim; Byung Chul Jeong; Ji Hee Lee; Hae Jin Kee; Hyun Kook; Nack Sung Kim; Yoon Ha Kim; Jong-Keun Kim; Kyu Youn Ahn; Kyung Keun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

7.  Regulation of the expression of caspase-9 by the transcription factor activator protein-4 in glucocorticoid-induced apoptosis.

Authors:  Kyoko Tsujimoto; Takeshi Ono; Masaki Sato; Takashi Nishida; Takemi Oguma; Takushi Tadakuma
Journal:  J Biol Chem       Date:  2005-06-08       Impact factor: 5.157

8.  Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.

Authors:  Junming Guo; Ying Miao; Bingxiu Xiao; Rong Huan; Zhen Jiang; Dan Meng; Yanjun Wang
Journal:  J Gastroenterol Hepatol       Date:  2008-11-03       Impact factor: 4.029

9.  Upregulation of activator protein-4 in human colorectal cancer with metastasis.

Authors:  Jie Cao; Minghua Tang; Wanglin L Li; Jintang Xie; Hong Du; Weibiao B Tang; Hui Wang; Xiwen W Chen; Huanqing Xiao; Yuyuan Li
Journal:  Int J Surg Pathol       Date:  2008-05-14       Impact factor: 1.271

10.  MicroRNA targets in Drosophila.

Authors:  Anton J Enright; Bino John; Ulrike Gaul; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  Genome Biol       Date:  2003-12-12       Impact factor: 13.583

View more
  6 in total

1.  Long intergenic noncoding RNA00265 promotes proliferation of gastric cancer via the microRNA-144-3p/Chromobox 4 axis.

Authors:  Zengxi Yang; Xi OuYang; Liang Zheng; Lizhen Dai; Wenjuan Luo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  miR‑144‑3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2.

Authors:  Longlong He; Lifan Liao; Liangzhi Du
Journal:  Int J Mol Med       Date:  2020-06-11       Impact factor: 4.101

3.  Long Non-coding RNA SNHG17 Promotes Cell Proliferation and Invasion in Castration-Resistant Prostate Cancer by Targeting the miR-144/CD51 Axis.

Authors:  Minghua Bai; Yutiantian Lei; Mincong Wang; Jinlu Ma; Pengtao Yang; Xingyi Mou; Yiping Dong; Suxia Han
Journal:  Front Genet       Date:  2020-04-15       Impact factor: 4.599

Review 4.  MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers.

Authors:  Omid Kooshkaki; Zohre Rezaei; Meysam Rahmati; Parviz Vahedi; Afshin Derakhshani; Oronzo Brunetti; Amir Baghbanzadeh; Behzad Mansoori; Nicola Silvestris; Behzad Baradaran
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

5.  lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.

Authors:  Pan Wang; Zhuanbo Yang; Ting Ye; Fei Shao; Jiagen Li; Nan Sun; Jie He
Journal:  J Exp Clin Cancer Res       Date:  2020-01-09

6.  MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion.

Authors:  Xin Shi; Xingfa Guan
Journal:  Diagn Pathol       Date:  2019-10-24       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.